Velta A. Lazda

406 total citations
24 papers, 339 citations indexed

About

Velta A. Lazda is a scholar working on Transplantation, Surgery and Immunology. According to data from OpenAlex, Velta A. Lazda has authored 24 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Transplantation, 7 papers in Surgery and 7 papers in Immunology. Recurrent topics in Velta A. Lazda's work include Renal Transplantation Outcomes and Treatments (10 papers), Renal Diseases and Glomerulopathies (6 papers) and Organ Transplantation Techniques and Outcomes (6 papers). Velta A. Lazda is often cited by papers focused on Renal Transplantation Outcomes and Treatments (10 papers), Renal Diseases and Glomerulopathies (6 papers) and Organ Transplantation Techniques and Outcomes (6 papers). Velta A. Lazda collaborates with scholars based in United States, Egypt and Indonesia. Velta A. Lazda's co-authors include Raymond Pollak, Martin F. Mozes, Olga Jonasson, Jason L. Starr, Afzal Nikaein, Nadim El‐Awar, Paul I. Terasaki, Peter Baram, Martin Rachmeler and J. Richard Thistlethwaite and has published in prestigious journals such as The Journal of Immunology, Clinical Orthopaedics and Related Research and Transplantation.

In The Last Decade

Velta A. Lazda

22 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Velta A. Lazda United States 9 207 156 81 60 58 24 339
E Ho United States 8 205 1.0× 171 1.1× 235 2.9× 29 0.5× 31 0.5× 15 419
Remi Shih United States 7 235 1.1× 140 0.9× 141 1.7× 21 0.3× 104 1.8× 9 386
Valeriya Zarkhin United States 8 262 1.3× 111 0.7× 219 2.7× 43 0.7× 79 1.4× 9 388
Juha Peräsaari Finland 12 109 0.5× 104 0.7× 68 0.8× 58 1.0× 32 0.6× 22 358
Eugenia K. Page United States 9 154 0.7× 118 0.8× 136 1.7× 17 0.3× 25 0.4× 12 308
Lena Marinova Bulgaria 8 141 0.7× 78 0.5× 155 1.9× 27 0.5× 70 1.2× 21 361
Q. Lansbergen Netherlands 10 99 0.5× 108 0.7× 123 1.5× 78 1.3× 12 0.2× 15 412
T Mohanakumar United States 14 150 0.7× 204 1.3× 134 1.7× 33 0.6× 7 0.1× 29 396
SD Marks United Kingdom 7 94 0.5× 55 0.4× 135 1.7× 23 0.4× 117 2.0× 18 311
Claire Leibler France 11 225 1.1× 81 0.5× 261 3.2× 44 0.7× 57 1.0× 18 476

Countries citing papers authored by Velta A. Lazda

Since Specialization
Citations

This map shows the geographic impact of Velta A. Lazda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Velta A. Lazda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Velta A. Lazda more than expected).

Fields of papers citing papers by Velta A. Lazda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Velta A. Lazda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Velta A. Lazda. The network helps show where Velta A. Lazda may publish in the future.

Co-authorship network of co-authors of Velta A. Lazda

This figure shows the co-authorship network connecting the top 25 collaborators of Velta A. Lazda. A scholar is included among the top collaborators of Velta A. Lazda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Velta A. Lazda. Velta A. Lazda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lazda, Velta A.. (2006). Evaluation of Epstein-Barr Virus (EBV) Antibody Screening of Organ Donors for Allocation of Organs to EBV Serostatus Matched Recipients. Transplantation Proceedings. 38(10). 3404–3405. 12 indexed citations
2.
Lazda, Velta A. & Martin F. Mozes. (2005). An Evaluation of HLA Cross-Reactive Group Matching on Graft Survival in Deceased Donor Kidney Recipients. Transplantation Proceedings. 37(2). 661–663. 4 indexed citations
3.
El‐Awar, Nadim, et al.. (2002). MOST PATIENTS WHO REJECT A KIDNEY TRANSPLANT HAVE ANTI‐HLA‐ANTIBODIES. Tissue Antigens. 60(6). 553–553. 4 indexed citations
4.
El‐Awar, Nadim, et al.. (2002). Almost all patients who are waiting for a regraft of a kidney transplant have anti-HLA antibodies. Transplantation Proceedings. 34(7). 2531–2532. 42 indexed citations
5.
Lazda, Velta A.. (2001). Sensitization to HLA by allografts is minimized by matching for HLA-A,B crossreactive groups. Transplantation Proceedings. 33(1-2). 393–394. 1 indexed citations
6.
Bartholomew, Amelia, Dorie Sher, Wendy Stock, et al.. (2001). STEM CELL TRANSPLANTATION ELIMINATES ALLOANTIBODY IN A HIGHLY SENSITIZED PATIENT1. Transplantation. 72(10). 1653–1655. 14 indexed citations
7.
Holman, Dawn M., Ty B. Dunn, M. Ward, et al.. (1999). Pretransplant MLC in the presence of cyclosporine may predict renal allograft survival. Transplantation Proceedings. 31(1-2). 746–747. 1 indexed citations
8.
Lee, Michael Y., Henry A. Finn, Velta A. Lazda, J. Richard Thistlethwaite, & Michael A. Simon. (1997). Bone Allografts Are Immunogenic and May Preclude Subsequent Organ Transplants. Clinical Orthopaedics and Related Research. 340(340). 215–219. 13 indexed citations
9.
10.
Lazda, Velta A., et al.. (1993). Presensitization and frequency of positive crossmatches in black and nonblack renal transplant candidates.. PubMed. 25(4). 2411–2. 6 indexed citations
11.
Ward, M., et al.. (1993). In vitro response to immunosuppressive agents in blacks.. PubMed. 25(4). 2470–1. 8 indexed citations
12.
Lazda, Velta A.. (1992). THE IMPACT OF HLA FREQUENCY DIFFERENCES IN RACES ON THE ACCESS TO OPTIMALLY HLA-MATCHED CADAVER RENAL TRANSPLANTS1. Transplantation. 53(2). 352–356. 27 indexed citations
13.
14.
Lazda, Velta A., Raymond Pollak, Martin F. Mozes, & Olga Jonasson. (1988). THE RELATIONSHIP BETWEEN FLOW CYTOMETER CROSSMATCH RESULTS AND SUBSEQUENT REJECTION EPISODES IN CADAVER RENAL ALLOGRAFT RECIPIENTS. Transplantation. 45(3). 562–565. 86 indexed citations
15.
Pollak, Raymond, et al.. (1986). THE SPLENIC MICROENVIRONMENT AND SELF RECOGNITION AS FACTORS IN ALLOGRAFT REJECTION IN RATS. Transplantation. 42(5). 528–531. 2 indexed citations
16.
Lazda, Velta A., et al.. (1983). Heart and spleen “twin grafts” in rats: IV. Influence of donor spleen cell mass on allograft survival. Microsurgery. 4(4). 233–235. 2 indexed citations
17.
Lazda, Velta A. & Peter Baram. (1979). In vitro Stimulation of Natural Killer (NK) Cells by Soluble Factor(s) Generated in Antigen-Stimulated Rhesus Monkey Peripheral Blood Lymphocyte Cultures. The Journal of Immunology. 122(5). 2068–2073. 5 indexed citations
19.
Lazda, Velta A., Jason L. Starr, & Martin Rachmeler. (1968). The Synthesis of Ribonucleic Acid during Early Antibody Induction. The Journal of Immunology. 101(2). 349–358. 5 indexed citations
20.
Lazda, Velta A., Jason L. Starr, & Martin Rachmeler. (1968). The Metabolism of Messenger RNA Synthesized after Primary Immunization. The Journal of Immunology. 101(2). 359–365. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026